HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
This study will evaluate HCW9302 in patients with moderate to severe alopecia areataMIRAMAR, Fla., Feb. 03, 2025 (GLOBE ...
Hosted on MSN7d
Innate Pharma doses first patient in Nectin-4 ADC trial
The Phase I trial will evaluate the safety and efficacy of the company’s drug which targets tumours whilst leaving normal ...
Business Wire1mon
Epirium Bio Announces FDA Clearance of Investigational New Drug Application for MF-300 and Appointment of Alex Casdin as New Chief Executive Officer and Russell Cox as ...
The U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for MF-300, a first-in-class orally administered, 15-hydroxyprostaglandin ...
BioSpace7dOpinion
Opinion: Contenders Vie to Challenge BioMarin in Achondroplasia Space
Achondroplasia, which affects around one in 20,000 babies, has just one approved treatment: BioMarin’s Voxzogo. However, new ...
Forbes1y
FDA Report Reveals 300% Increase In Cannabis Research Over The Last Decade—Key Findings
The last decade has seen a “dramatic increase” in investigational new drug (IND) applications for cannabis-derived products, according to the U.S. Food and Drug Administration. In a paper ...
Business Insider27d
Solid Biosciences's IND For Gene Therapy To Treat Friedreich's Ataxia Gets FDA Clearance
(RTTNews) - Life sciences company Solid Biosciences Inc. (SLDB), Tuesday announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for ...